Document Detail


Sleep-related breathing in children with mucopolysaccharidosis.
MedLine Citation:
PMID:  19562504     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The mucopolysaccharidoses (MPSs), a group of genetic lysosomal storage disorders, are associated with significant morbidity. Secondarily to specific associated anatomical abnormalities, MPS is associated with sleep disordered breathing (SDB), specifically obstructive sleep apnoea (OSA) that may confer additional morbidity. Few studies have examined SDB in children with MPS using full polysomnography (PSG) and thus the exact prevalence and severity of SDB is unknown. Further, successful treatments for SDB in this population have not been explored. OBJECTIVES: This study evaluated both SDB and the efficacy of treatments offered to children with MPS using PSG data. PATIENTS AND METHODS: A retrospective chart review was conducted on all children with MPS and a history of suspected OSA who were referred to the Hospital for Sick Children, Toronto. Both baseline and follow up treatment PSG data were analysed. PSG data recorded included obstructive apnoea-hypopnoea index (OAHI) and central apnoea index (CAI). RESULTS: Fourteen patients (10 male) underwent a baseline PSG. Three of 14 children on ERT were excluded from the main analyses. The median (range) baseline parameters of the population (n = 11) were recorded. The age was 5.2 years (0.8-17.8) and the body mass index (BMI) was 19.9 (13.7-22.2). The OAHI was 6.6 (0.0-54.8); the CAI was 0.6 (0.0-2.6). Seven of 11 (64%) had evidence for OSA and 3/7 children were classified as having severe OSA (OAHI > 10). Of these, 5/7 children underwent treatment for OSA with 3/5 children showing a significant reduction in their OAHI. Further, the 2 patients on ERT therapy with OSA were also both successfully treated. CONCLUSIONS: Children with MPS have a high prevalence of significant OSA and thus should be carefully screened for OSA using full polysomnography and treated accordingly.
Authors:
A Nashed; S Al-Saleh; J Gibbons; I MacLusky; J MacFarlane; A Riekstins; J Clarke; I Narang
Related Documents :
21381834 - A psychometric analysis of the positive and negative affect schedule for children-paren...
22111544 - Social and behavioural outcomes in children diagnosed with autism spectrum disorders: a...
22150054 - Drug-resistant epilepsy.
23726954 - Habitual use of push and pull plastic bottle caps is more prevalent among children with...
11844034 - Incisal and condylar paths during habitual mouth opening movement of children with ante...
23746614 - White matter abnormalities in pediatric obsessive-compulsive disorder.
Publication Detail:
Type:  Journal Article     Date:  2009-06-28
Journal Detail:
Title:  Journal of inherited metabolic disease     Volume:  32     ISSN:  1573-2665     ISO Abbreviation:  J. Inherit. Metab. Dis.     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-08-12     Completed Date:  2009-11-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7910918     Medline TA:  J Inherit Metab Dis     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  544-50     Citation Subset:  IM    
Affiliation:
The Hospital for Sick Children, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetates / therapeutic use
Adolescent
Anti-Asthmatic Agents / therapeutic use
Child
Child, Preschool
Female
Humans
Infant
Male
Mucopolysaccharidoses / complications*,  epidemiology,  physiopathology,  therapy
Polysomnography
Positive-Pressure Respiration
Prevalence
Quinolines / therapeutic use
Respiration
Retrospective Studies
Sleep / physiology
Sleep Apnea Syndromes / complications*,  epidemiology,  physiopathology,  therapy
Tonsillectomy / methods
Treatment Outcome
Chemical
Reg. No./Substance:
0/Acetates; 0/Anti-Asthmatic Agents; 0/Quinolines; 158966-92-8/montelukast

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Orotic aciduria and uridine monophosphate synthase: A reappraisal.
Next Document:  Long-term neurodevelopmental effects of early detection and treatment in a 6-year-old patient with a...